Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir
- PMID: 15325433
- DOI: 10.1016/j.ijantimicag.2004.04.005
Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir
Abstract
The use of tenofovir as part of a HAART regimen has been widely used in HIV-multi-experienced-patients because of its favourable resistance profile. Tenofovir is mainly eliminated by the kidneys and renal toxicity should be carefully monitored. We describe here the case of an HIV-infected patient, without a prior history of renal failure who developed nephrolithiasis and hydronephrosis after starting a tenofovir-containing HAART regimen.
Similar articles
-
Adverse effects of tenofovir use in HIV-infected pregnant women and their infants.Ann Pharmacother. 2008 Nov;42(11):1581-5. doi: 10.1345/aph.1L083. Epub 2008 Oct 28. Ann Pharmacother. 2008. PMID: 18957630
-
Improvement of dyslipidemia during different HAART regimens: tenofovir- versus stavudine-containing antiretroviral combinations.Clin Infect Dis. 2006 May 1;42(9):1345-7; author reply 1347-8. doi: 10.1086/503309. Clin Infect Dis. 2006. PMID: 16586399 No abstract available.
-
Acute renal failure in HIV patients with liver cirrhosis receiving tenofovir: a report of two cases.AIDS. 2006 Aug 22;20(13):1786-7. doi: 10.1097/01.aids.0000242830.27990.93. AIDS. 2006. PMID: 16931948 No abstract available.
-
Tenofovir: what have over 1 million years of patient experience taught us?Int J Clin Pract. 2008 Aug;62(8):1285-93. doi: 10.1111/j.1742-1241.2008.01817.x. Int J Clin Pract. 2008. PMID: 18705824 Review.
-
Tenofovir and didanosine: a dangerous liaison.AIDS Read. 2005 Aug;15(8):403-6, 413. AIDS Read. 2005. PMID: 16110555 Review. No abstract available.
Cited by
-
Formulation Design, Optimization, and Evaluation of Solid Lipid Nanoparticles Loaded With an Antiviral Drug Tenofovir Using Box-Behnken Design for Boosting Oral Bioavailability.Adv Pharmacol Pharm Sci. 2024 Dec 31;2024:5248746. doi: 10.1155/2024/5248746. eCollection 2024. Adv Pharmacol Pharm Sci. 2024. PMID: 39781028 Free PMC article.
-
Drug-induced kidney stones: a real-world pharmacovigilance study using the FDA adverse event reporting system database.Front Pharmacol. 2025 Mar 27;16:1511115. doi: 10.3389/fphar.2025.1511115. eCollection 2025. Front Pharmacol. 2025. PMID: 40213702 Free PMC article.
-
Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.Drugs. 2018 Feb;78(2):163-201. doi: 10.1007/s40265-017-0853-7. Drugs. 2018. PMID: 29264783 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical